Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

UKONS 2020 | Launching a self-administration service during the COVID-19 pandemic

Lisa Barrot • 20 Nov 2020
UKONS 2020
General Bortezomib Cytarabine Denosumab Trastuzumab

Lisa Barrot, BSc, Ba, MSc, PhD, The Royal Marsden NHS Foundation Trust, London, UK, outlines the process of launching a self-administration service at the Royal Marsden NHS Foundation Trust, during the ongoing COVID-19 pandemic and associated challenges. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Lisa Barrot

4:13
Cancer nursing response to COVID-19
Lisa Barrot • 20 Nov 2020

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals